Bain Capital Public Equity Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bain Capital Public Equity Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-486,672	Closed	-$5.51M	–	21
2019 Q1	$5.51M	Buy	+486,672	New	+$5.44M	0.53%	35
2018 Q2	–	Sell	-348,232	Closed	-$4.5M	–	80
2018 Q1	$4.5M	Buy	+348,232	New	+$4.34M	0.33%	46

Other funds holding IRWD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Bain Capital Public Equity Management's IRWD Position: Q2 2019 in Review

Bain Capital Public Equity Management sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2019, closing a stake of 486,672 shares — an estimated $5.51M sold.

Bain Capital Public Equity Management first reported a position in IRWD in Q1 2018 and held it in 2 quarters. The position peaked at $5.51M in Q1 2019. 152 funds tracked by Wall St. Rank hold IRWD as of Q2 2019.

Bain Capital Public Equity Management reported no remaining Ironwood Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
Bain Capital Public Equity Management sold 486,672 Ironwood Pharmaceuticals shares in Q2 2019, an estimated $5.51M.
Bain Capital Public Equity Management first reported a position in Ironwood Pharmaceuticals in Q1 2018 and held it in 2 quarters.
Bain Capital Public Equity Management's Ironwood Pharmaceuticals position peaked at $5.51M in Q1 2019.
152 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2019.

Based on Bain Capital Public Equity Management's 13F filing for Q2 2019.